There have been a few posts here saying that a rights issue is the best CR option as it would be the least dilutive. However looks like instos can buy into the 20m initial tranche and still double dip with the right issue? 1 for every 9.4 shares now rather than the initial 1 for 7 flagged over the weekend
Sell off this week then buy back in at much lower prices and no cons at all
Or am i missing something?
As a shareholder its dissapointing that they didnt wait until after an EMA announcement at the very least
$15m cap raise Fresh Equities at 24c, page-246
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $177.5K | 1.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 136159 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 233891 | 3 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |